Ceapro Inc V.CZO

RE:RE:Why words are meaningless

[prophetoffactz]

Ciao, "There's always next year right?"

Ciao hasn't even been able to get his Stockhouse posts right the first time and here he is demanding Gilles get complex science right like PGX the first time that have never been done before in human history. Ciao further hyped Xebec on this message board multiple times shortly before it went bankrupt. Ciao's demands are ludicrous. Gilles is leading the world, period. That Gilles now has second-generation PGX carriers that have blown away the bioavailability of prototype PGX-OBG should get Ciao's applause. Informed by discussions with industry PGX-YBG appears to address all of industry's needs. It is believed easier and cheaper to process. PGX-YBG appears to set a new standard for an immune booster - 5X more binding affinity in human cell-lines. PGX-YBG could profoundly change the landscape for fibrosis treatment according to Dr. Martin Kolb. Given the bioavailability results and that PGX-YBG is clearly swallowable by macrophages argues for CZO having developed a Trojan Horse that will allow the delivery of other bioactives and drugs. 

Ciao is trying to run down a man who has went up against industry Golaiths and is poised to win. Simultaneous 5X and 10X scale-up, including with industry leader Natex, is underway right now. 50% of the equipment and infrastructure that will take PGX to the point of decision for mass industrialization was in place as of November. Ronny Miller is "thrilled". The merger arguably fully finances CZO's near-term development needs at a target price of $1.25 without warrants in a very difficult financing environment. That is to be commended. Gilles results driven approach is the stuff of legends. He is poised to set new gold standards in multiple categories. The stock price will take care of itself with events which are all lined up. The market doesn't have the key information at the moment. 

   The path,
the daisy chain of events that will define this merger...

AEZS's diagnostic test clinical trial results for children
Launch of powder formulations of CZO's two active ingredients(beta glucan, avenanthramide)
CZO's main client returns
AEZS's diagnostic continuing roll-out for adults
FDA approval for the test for children
Licensing deal for the diagnostic test for North America
Commissioning of 5X PGX scale-up
Commissioning of 10X scale-up to decision point for mass industrialization of PGX
PGX licensing deal
Immune booster plant
Phase I avenanthramide clinical trial results
Wound healing results
Wound healing partnership
Fibrosis clinical trial 'go'/'no go' decision and regulatory filing
Phase IIa avenanthramide clinical trial results
Avenanthramide pill partnership
AIM Biologicals 'go'/'no go' clinical trial decision